Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma

Background and Objectives: Intrahepatic cholangiocarcinoma (iCCA) is a pernicious tumor characterized by a dismal outcome and scarce therapeutic options. To substantially improve the prognosis of iCCA patients, a better understanding of the molecular mechanisms responsible for development and progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Cigliano, Antonio, Pilo, Maria Giulia, Mela, Marta, Ribback, Silvia, Dombrowski, Frank, Pes, Giovanni Mario, Cossu, Antonio, Evert, Matthias, Calvisi, Diego Francesco, Utpatel, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023300/
https://www.ncbi.nlm.nih.gov/pubmed/31861475
http://dx.doi.org/10.3390/medicina56010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023300/
https://www.ncbi.nlm.nih.gov/pubmed/31861475
http://dx.doi.org/10.3390/medicina56010001

Ejemplares similares